Interruption of BCG Therapy for NMIBC During COVID-19 Crisis, Dilemma in Its Continuation: a Review of Available Evidence and Suggested Management Strategies-Reference-Cited by-同舟云学术

Interruption of BCG Therapy for NMIBC During COVID-19 Crisis, Dilemma in Its Continuation: a Review of Available Evidence and Suggested Management Strategies

Published:2023-04-03 Issue:3 Volume:14 Page:682-689
ISSN:0975-7651
Container-title:Indian Journal of Surgical Oncology
language:en
Short-container-title:Indian J Surg Oncol

Author:

Tosh Jyoti Mohan,Panwar Vikas Kumar^ORCID,Mittal Ankur,Mandal Arup Kumar

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Surgery

Link

https://link.springer.com/content/pdf/10.1007/s13193-023-01742-8.pdf

Reference36 articles.

1. Sohrabi C, Alsafi Z, O’Neill N, Khan M, Kerwan A, Al-Jabir A et al (2020) World Health Organization declares global emergency: a review of the 2019 novel coronavirus (COVID-19). Int J Surg 76:71–76

2. Ribal M, Cornford P, Briganti A, Knoll T, Gravas S, Babjuk M et al (2020) European Association of Urology Guidelines Office Rapid Reaction Group: an organisation-wide collaborative effort to adapt the European Association of Urology Guidelines recommendations to the coronavirus disease 2019 Era. Eur Urol 78(1):21–28

3. Morales A, Eidinger D, Bruce A (1976) Intracavitary Bacillus Calmette-Guerin in the treatment of superficial bladder tumors. J Urol 116(2):180–182

4. Venkataswamy MM, Goldberg MF, Baena A, Chan J, Jacobs WR Jr, Porcelli SA (2012) In vitro culture medium influences the vaccine efficacy of Mycobacterium bovis BCG. Vaccine 30(6):1038–1049

5. Oettinger T, Jorgensen M, Ladefoged A, Haslov K, Andersen P (1999) Development of the Mycobacterium bovis BCG vaccine: review of the historical and biochemical evidence for a genealogical tree. Tuber Lung Dis 79(4):243–250